Decitabine Intravenous and Insulin glargine and lixisenatide
Determining the interaction of Decitabine Intravenous and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: decitabine
Brand name: Dacogen
Synonyms: Decitabine
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Decitabine Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Decitabine Intravenous-Insulin glargine, recombinant Subcutaneous
- Decitabine Intravenous-Insulin glulisine
- Decitabine Intravenous-Insulin Glulisine (Cartridges and Pens)
- Decitabine Intravenous-Insulin Glulisine (Vials)
- Decitabine Intravenous-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Declomycin
- Insulin glargine and lixisenatide-Decon-A
- Insulin glargine and lixisenatide-Deconamine (Chlorpheniramine and Pseudoephedrine Liquid)
- Insulin glargine and lixisenatide-Deconamine (Chlorpheniramine and Pseudoephedrine Tablets)
- Insulin glargine and lixisenatide-Deconex
- Insulin glargine and lixisenatide-Deconex DMX